IMCI Pharmaceuticals

A pharmaceutical company developing novel and patented cannabis-based medicines to treat neuropathic pain and chronic indications.

Health Tech & Life Sciences
Active
Pre-Funding Gan Yavne, Israel Founded 2018
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
9
HQ
Gan Yavne, Israel
Sector
Health Tech & Life Sciences

About

IMCI Pharmaceuticals is an Israeli pharmaceutical company that develops innovative pharma-grade and formulated cannabis-based medications to treat chronic indications with a global reach. They have developed a precise and effective dose with an easy-to-use administration via their iCann medicinal cannabis platform. Their research and development is based on an Israeli leading academic research institution in collaboration with established Israeli pharmaceutical providers. IMCI aims to provide patients suffering from chronic and neuropathic pain with effective pain relief, quick onset, long-lasting therapeutic effect, and reduced negative side effects. The company views itself as an R&D startup and is focused on creating nanoparticles out of cannabis for more effective delivery of cannabinoids.

Headcount over time

From 2 (2020-06) to 6 (2026-01) · +4 (+200%) · 6 points · source: Finder history + radar grounding
90 2020-06 2026-01

Q&A

What is IMCI Pharmaceuticals' primary focus?
IMCI Pharmaceuticals is a pharma-grade medical cannabis company focused on redefining patient care through science, safety, and precision.
What is IMCI Pharmaceuticals' proprietary technology?
IMCI Pharmaceuticals utilizes its proprietary NanoVATE™ drug-delivery platform to enhance cannabinoid bioavailability.
What products does IMCI Pharmaceuticals offer?
IMCI Pharmaceuticals offers the iCann product line, which includes iCann Fast, iCann Oral, and iCann LA, designed for fast, accurate, and long-lasting relief.
Where is IMCI Pharmaceuticals expanding its operations?
IMCI Pharmaceuticals is expanding its operations across Europe, Israel, and the U.S.
When was IMCI Pharmaceuticals founded?
IMCI Pharmaceuticals was founded in December 2018.
How many employees does IMCI Pharmaceuticals have?
IMCI Pharmaceuticals has 1-10 employees.
What is the current funding stage of IMCI Pharmaceuticals?
IMCI Pharmaceuticals is currently in the Pre-Funding stage.
Does IMCI Pharmaceuticals hold any patents?
Yes, IMCI Pharmaceuticals holds 1 patent.

Team · 2

Alon Hershkovitz
Founder · Co-Founder
Avi Yakobovich
Founder · Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2CB2B

Highlights

1 PatentsVerified

Tags

oncologydrug-developmentcannabispain-relieftreatmentspain-freetherapeuticsdrug-deliverydrug-discoverypharmaceuticalsbiopharmaceuticalmedical-cannabisbiotechnologycancerchronic-painpharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)